Introduction
============

It is well known that both stress-induced and age-induced cognitive dysfunctions are major public health issues nowadays. More particularly, it has been shown that stress and aging impair in humans declarative memory, and more specifically memory processes involving either the hippocampus (HPC) and/or prefrontal cortex activity (de Quervain et al., [@B12]; Cappell et al., [@B4]). Moreover, both stress-induced and aged-induced memory impairments would involved dysfunction of the HPA axis activity (Sapolsky et al., [@B35]; de Kloet et al., [@B11]; Lupien et al., [@B26]; Pardon, [@B29]; Pardon and Ratray, [@B30]; Comijs et al., [@B9]).

In line with these observations, we recently showed that stressed middle-aged mice exhibited contextual memory impairments associated with a dramatic increase in intra-HPC corticosterone concentration (Tronche et al., [@B39]). We already evidenced the causal role of HPC corticosterone on memory dysfunction in stressed middle-aged mice insofar as the administration of metyrapone (an inhibitor of corticosterone synthesis) totally alleviated both the stress-induced corticosterone rise and memory impairments (Tronche et al., [@B39]). In addition, we also showed that the direct infusion of corticosterone into the HPC of young adult mice induced memory impairments similar to those observed in stressed middle-aged mice (Chauveau et al., [@B6], [@B8]).

Because of the impact of benzodiazepines (BDZ) on GABAergic neurons, these compounds are widely prescribed in the treatment of anxiety disorders associated to aging. Indeed, it has been shown that aging causes organisms to become vulnerable to stress, which might be mediated by dysfunction of the brain system regulating emotional and stress responses (Pardon and Ratray, [@B30]; Shoji and Mizoguchi, [@B36]). However, it is also known that compounds modulating GABA-A receptors such as BDZ, also affect HPC-dependent memory functions (for review, see Beracochea, [@B2]). Furthermore, it has already been demonstrated that GABAergic neurons also act on hypothalamic nuclei of the HPA axis (Jones et al., [@B21]; Hillhouse and Milton, [@B18]; Stotz-Potter et al., [@B38]; Cullinan et al., [@B10]) and that peripheral injection of GABA-A receptor positive modulators such as BDZ reduced HPA axis activity (Imaki et al., [@B19]; Grottoli et al., [@B16]).

Given the reciprocal interaction between the GABAergic system and HPA axis, it is of importance to determine the impact of BDZ administration on HPA axis activity and its consequence on memory function, in particular in middle-aged subjects that are vulnerable to stress. So far, the aim of the present study was to evidence more specifically the impact of BDZ administration on HPC glucocorticoids concentration and its consequence on memory in a HPC-dependent contextual memory task in stressed middle-aged mice.

For that purpose, we studied in a first experiment the effects of a diazepam administration on contextual memory, using the contextual serial discrimination task (CSD). This task allowed to evidence a hippocampal-dependent memory impairment in stressed (Celerier et al., [@B5]; Piérard et al., [@B34]) as well as in middle-aged (Tronche et al., [@B39]) and aged subjects (Tronche et al., [@B40]). More precisely, the CSD task involves two serial discriminations (D1 and D2) learned on two different contexts. We found from *in situ* brain lesions and pharmacological experiments, that the memory retrieval of D1 but not of D2 is HPC-dependent (Chauveau et al., [@B7], [@B6], [@B8]). In a second experiment, we evaluated the emotional status of diazepam-treated stressed middle-aged mice in an elevated plus-maze task. Finally, in a third experiment, we measured by *in vivo* microdialysis the intra-HPC corticosterone concentration following diazepam administration in freely moving mice. Microdialysis allows a direct and dynamic measurement of the interaction between the HPA axis and the HPC, as a function of the administered dose of diazepam. Whereas peripheral measurements of circulating glucocorticoids have already been performed (Comijs et al., [@B9]), there is to our knowledge no direct evidence for such a dynamic interaction at the hippocampal level, which is surprising given the known importance of the hippocampus both in memory processes and in the negative feedback exerted by this brain area on HPA axis activity.

Materials and Methods
=====================

Animals
-------

Upon arrival in the laboratory, all animals were 3-month-old male mice of the BALB/c inbred strain obtained from Charles River (L\'Arbresle, France). Animals were housed in collective cage in the colony room (12 h light--dark cycle in a temperature controlled and ventilated room) until they were either 16 months. Two weeks before the experiments, they were housed individually. The animal\'s weights were ranged between 28 and 35 g at the time of experiments. All procedures were carried out during the light phase of the cycle, between 08:00 and 12:00 a.m. During the food deprivation phase, mice were handled daily so as to become familiar with the experimenter. During that phase, all subjects were maintained at 85--90% of their *ad libitum* body weight throughout the behavioral study. All animal experimentation reported in the present paper has been conducted in accordance with the guidelines laid down by the European Communities Council.

Memory test
-----------

### Apparatus

The CSD has been extensively described in earlier studies (Chauveau et al., [@B6], [@B8]; Pierard et al., [@B33]). All tests were performed in a four-hole board apparatus (45 cm × 45 cm × 30 cm high) enclosed by gray Plexiglas. The four-hole board apparatus was placed on the floor of the room (3.0 m × 3.0 m × 2.40 m high). The floor of the board was interchangeable (white and rough; black and smooth). On the floor, four holes opening on a food cup (3 cm in diameter × 2.5 cm in depth) were located 6 cm away from the sidewalls. The apparatus was placed in a room exposed to a 60-dB background noise and a light centered over the apparatus provided 20 lx intensity at the position of the apparatus. The apparatus was cleaned with 95% ethanol, then with water before each mouse behavioral testing. Data were automatically monitored by photoelectric cells and video recording.

### Acquisition phase

In the CSD, the acquisition phase took place in room A where animals learned two consecutive spatial discriminations (D1 and D2; see Figure [1](#F1){ref-type="fig"}). Both discriminations differed in terms of the color and texture of the floor (internal context of the four-hole board) and were separated by a 2-min delay interval. During this delay, the mouse was returned to its home cage in room B. At the beginning of acquisition and retrieval phases, mice were placed in the center of the four-hole board in an opaque PVC tube for 5 s to provide the animal with a random start in the apparatus. For D1, ten 20-mg food pellets were available only in one of the four holes on the board for 6 min. Location of the baited hole for D1 was randomized for each subject. For D2, ten 20-mg food pellets were consistently located in the opposite symmetrical hole, for 6 min likewise. The environmental spatial cues were made of colored and striped paper sheets positioned at 1.00 m above the four-hole board. These allocentric cues remained at the same place for both D1 and D2 discriminations and for the retrieval phase. Thus, both discriminations D1 and D2 differed only by the internal (floor) contextual cues. Both floors were positioned in a mixed random order during the acquisition of the first and second discrimination tasks. At the end of the acquisition phase, mice returned to their home cage in the animal room for 24 h. Only mice having eaten all the pellets during both acquisition sessions were used for the retrieval test phase.

![**Description of the contextual serial discrimination (CSD) behavioral task**. **(A)** Behavioral procedures. **(B)** Type of responses for the retrieval test phase. D1, discrimination 1; D2, Discrimination 2; CSD, contextual serial discrimination. During retrieval test phase, each mice is randomly evaluated either on D1 floor or D2 floor without food reward.](fnbeh-05-00014-g001){#F1}

### Acute stress

Twenty-four hours after acquisition, mice were placed in the stress delivery cage for 1 min, in room D. Stress was induced 15 min before the test session. Stressed mice received three consecutive inescapable electric foot-shocks (0.9 mA; 10 ms). All animals were then returned to their home cage during the delay preceding the test session.

### Test phase

Fifteen minutes after acute stress, mice were replaced in the four-hole board (room A) without any pellet in the apparatus. Mice were placed either on the D1 floor *or* on the D2 floor and were allowed to freely explore the apparatus for 6 min. For all mice, the retrieval test phase occurred 24 h after the acquisition phase and was performed on independent groups for either D1 or D2. Performance was assessed by measuring the number of head dips in each hole during 6 min.

### Measurements

Memory retrieval performance was evaluated through the exploration rates into the different holes. *Correct responses* were defined as head dips into the hole previously baited on the same floor-context during the acquisition phase, and were calculated as follows: (head dips into the baited hole/total number of head dips in the four holes) × 100.

Evaluation of emotional status
------------------------------

### Elevated plus maze

In order to verify the anxiolytic action of diazepam and the absence of sedative effect for the selected doses, stressed animals were submitted to the elevated plus-maze task 15 min after electric shock delivery. Stress was similar as the one previously described in the CSD experiments. The elevated plus maze, which was constructed of gray Plexiglas, consisted of four arms arranged in the shape of a plus sign. Each arm was 30 cm long, 7 cm wide, and was elevated 40 cm above the ground. The four arms were joined at the center by a 7-cm square platform. Two opposite arms of the plus maze were enclosed by sidewalls 17 cm high, but open on the top. The remaining arms did not have sidewalls. These walls did not extend from the center of the maze. The experiment was performed between 08:30 and 12:00 a.m. At the beginning of the session, mice were placed at the center of the plus maze in a cylinder (8 cm diameter, 17 cm high) for 30 s. Then, the cylinder was removed and mice were allowed to freely explore all arms of the maze for 6 min. An entry was counted only when a mouse entered an arm with all four paws. "Anxiety-like" behavior was measured by the ratio of entries into the open arms divided by the total number of entries in all arms (entry ratio). Results were expressed in percentages (ratio × 100). The elevated plus-maze test has been performed in four independent groups of mice (i.e., not submitted to the CSD task and microdialysis experiment) distributed as follows: vehicle: *n* = 7; diazepam 0.25 mg/kg: *n* = 7; diazepam 0.5 mg/kg: *n* = 7; diazepam 1.0 mg/kg: *n* = 7).

Surgery and histology
---------------------

Mice were anesthetized with a ketamine (100 mg/kg body weigh)--xylazine (10 mg/kg body weigh) mixture and placed into a stereotaxic frame. A single guide cannula microdialysis (CMA/7 Microdialysis probe, CMA Microdialysis, Sweden) was implanted in the bottom of the parietal cortex at the following coordinates from the bregma (Paxinos and Franklin, [@B32]): Antero-posterior = −2000 μm, Lateral = +1400 μm, and Vertical = −800 μm. The guide cannula was fixed with dental cement and three micro screws attached to the skull. All operated mice were allowed to recover in their home cages in the animal room for at least 7 days before the microdialysis experiment. On the day of the experiment, the microdialysis probe was lowered 1 mm below through the guide cannula so that the microdialysis membrane is located into the dorsal HPC. At the end of the microdialysis experiment, mice were anesthetized and then transcardially perfused in the left ventricle with saline solution (NaCl 0.9%) followed by formaldehyde (4%). Brains were then postfixed in a 4% formaldehyde solution for 10 days, then in a saccharose--formaldehyde solution (30 and 4% v/v) for 2 days. All the brains were sectioned coronally (50 μm thickness). A cresyl violet stain was used to locate the microdialysis probe with utmost accuracy.

*In vivo* microdialysis
-----------------------

Seven days after surgery, a dialysis probe (CMA/7; CMA Microdialysis AB, Sweden; length: 1 mm; molecular cut-off 6 kDa and membrane outer diameter: 0.24 mm) was carefully implanted into the right dorsal HPC under light anesthesia induced by a ketamine (50 mg/kg body weigh)--xylazine (5 mg/kg body weigh) mixture. Mice were then individually housed in a system allowing animals to move freely (CMA/120; CMA Microdialysis AB, Sweden) overnight. After the overnight perfusion at 1 μl/min to equilibrate extracellular metabolites concentrations, freely moving animals were continuously perfused with a sterile-filtered saline solution (Dulbecco\'s phosphate buffered saline; SIGMA; in g/l: CaCl~2~, 0.133; MgCl~2~, 0.1; KCl, 0.2; KH~2~PO~4~, 0.2; NaCl 8.0; Na~2~HPO~4~, 1.15; pH between 7.1 and 7.5) at a 1-μl/min flow rate through a micro-infusion pump. The foot-shock delivery system was inside the dialysis cage in order to deliver acute stress. Microdialyzates were sampled every 15 min using tubes with a dead volume of 1.2 μl/100 mm length (CMA Microdialysis AB). Samples were stored at −80°C. Baseline dialyzates were collected for 1 h before *ip* injection of diazepam (*n* = 8 for each dose) or vehicle (*n* = 8) and 30 min before acute stress delivery. Free corticosterone levels measured in the dialyzate (in nanomolar) were expressed as the percentage of the averaged baseline values collected before the injection.

Drug administration
-------------------

Five days before experiments, mice were daily prepared for intraperitoneal (*ip*) administration by exerting light pressure on the body with the syringe. On the day of the experiment, 30 min before acute stress administration, mice received an *ip* injection of a diazepam solution. Diazepam (Valium^®^, Roche, 1, 0.5, 0.25 mg/kg body weigh dissolved in saline solution) and vehicle (saline solution) solutions were injected in a room (room C, Figure [1](#F1){ref-type="fig"}) different from the behavioral room (room A).

Intra-hippocampal corticosterone assay
--------------------------------------

A commercially prepared Enzyme Immunoassay kit was used to measure HPC corticosterone concentrations in the microdialyzates (Correlate-EIA™, Assay Designs, Ann Arbor, USA). The sensitivity of the assay was 0.08 nmol/l. Therefore, baseline sample concentration was more than 10-fold superior than sensitivity threshold.

Statistical analyses
--------------------

Statistical analyses were performed using the Sigma Plot 11.0 software. Behavioral data were analyzed using 1 way or 2 way factorial analyses of variance (ANOVAs) with either "Treatments" and "Discriminations" as factors followed, -- when adequate, with *post hoc* comparisons (Bonferroni\'s *t*-test). In the CSD task, comparisons of retrieval performances with chance level were calculated with paired-samples *t*-test (with hypothesized mean = chance level = 25% for correct responses).

For microdialysis, basal free extracellular corticosterone levels were compared with one sample Student\'s *t*-test. Stress effects on intra-HPC corticosterone levels are expressed in percentage of baseline variation. They were compared using two-way repeated-measures ANOVA (RM-ANOVA) with both "Treatments" and "Time" factors. When appropriate, *post hoc* analyses were performed with Bonferroni\'s *t*-test.

All the data were expressed as mean ± SEM and "NS" means that "*p*" values exceed 0.05 and are considered as non-statistically significant.

Ethical statement
-----------------

The present study was carried out in compliance with the European Convention for the protection of Vertebrate Animals used for Experimental and other Scientific Purposes, under the agreement \#2010/11 delivered by the French Ministry of Defence after the protocol was examined by the local ethical committee. Guidelines for proper laboratory animal care were fully implemented.

Results
=======

Experiment 1: CSD task
----------------------

### Acquisition phase

The acquisition phase has been analyzed according to the further random attribution of mice to D1 (Vehicle: *n* = 10; 0.25 mg/kg: *n* = 9; 0.5 mg/kg: *n* = 9; 1.0 mg/kg: *n* = 9) or D2 (Vehicle: *n* = 10; 0.25 mg/kg: *n* = 9; 0.5 mg/kg: *n* = 9; 1.0 mg/kg: *n* = 9) as regards the retrieval test phase and the post-stress delay. Total numbers and percentage of head dips are reported in Table [1](#T1){ref-type="table"}. The Student\'s *t*-test is used for comparisons between D1 and D2.

###### 

**Total number of head dips and % number of head dips in the rewarded hole of acquisition 1 and acquisition 2 in vehicle and diazepam-treated groups**.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------
                        Total number\         Percent of head\   Student\'s *t*-test on the percentage\                                  
                        dips in baited hole   of head dips       of head dips in baited hole                                             
  --------------------- --------------------- ------------------ ---------------------------------------- ------------ ----------------- -------------------------
  Vehicle *n* = 20      56.5 ± 1.7            64.9 ± 1.4         60.7 ± 2.8                               56.5 ± 4.9   *t* = 0.739, NS   

  1 mg/kg *n* = 18      63.7 ± 4.2            62.8 ± 6.2         65.6 ± 6.4                               67.8 ± 3.8   *t* = 0.631, NS   for D1, *t* = 0.738, NS

                                                                                                                                         for D2, *t* = 1.793, NS

  0.5 mg/kg *n* = 18    58.1 ± 3.4            61.1 ± 6.9         56.3 ± 2.8                               63.6 ± 5.4   *t* = 1.131, NS   for D1, *t* = 1.107, NS

                                                                                                                                         for D2, *t* = 0.917, NS

  0.25 mg/kg *n* = 18   60.1 ± 3.8            65.4 ± 4.4         58.4 ± 8.1                               62.4 ± 5.5   *t* = 0.413, NS   for D1, *t* = 0.283, NS

                                                                                                                                         for D2, *t* = 0.802, NS
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------

*There is no significant between groups difference*.

### Test phase

A two-way ANOVA performed on all groups (vehicle; Diazepam 0.25 mg/kg, Diazepam 0.5 mg/kg, and Diazepam 1.0 mg/kg) showed a significant interaction between Discriminations × Treatments \[*F*~(3,66)~ = 33.049; *p* ≤ 0.001; Figure [2](#F2){ref-type="fig"}\].

![**Effect of stress on contextual memory in vehicle and diazepam (0.25, 0.5, and 1 mg/kg) treated mice**. Memory performance was evaluated by the percentage of correct responses for D1 and D2 in the CSD task. Each animal were evaluated either on the D1 either on D2. All groups received *ip* injection (vehicle or diazepam) 30 min before the stress delivery. All animals were evaluated 15 min after the stress delivery. Numbers of animals used for each group are mentioned in histograms. Comparison to vehicle groups: \**p* ≤ 0.05; \*\**p* ≤ 0.01; \*\*\**p* ≤ 0.001. Dotted lines represent chance level.](fnbeh-05-00014-g002){#F2}

1.  Vehicle. Vehicle-treated mice exhibited performance for D1 and D2 significantly different from chance level (25%; 17.8 ± 2.5%; *t* = 3.552; *p* ≤ 0.01 and 46.3 ± 2.5%; *t* = 8.663; *p* ≤ 0.001 respectively as compared to chance level). Bonferroni\'s *t*-test reveals significant memory performances differences between D1 and D2 (17.8 ± 2.5 and 46.3 ± 2.5% respectively; *t* = 8.218; *p* ≤ 0.001).

2.  Diazepam 0.25 mg/kg. Within-group analyses showed that D1 performance in 0.25 mg/kg treated mice was at chance (28.7 ± 5.7%; *t* = 1.943; NS) but was significantly above chance level for D2 (34.6 ± 6.3%; *t* = 5.434; *p* ≤ 0.001). Bonferroni\'s *t*-test did not reveal any differences between D1 and D2 (28.7 ± 5.7 and 34.6 ± 6.3% respectively; *t* = 1.631; NS). In addition, cross-analyses were performed as compared to vehicle-treated group on independent groups of mice. Inter-group comparisons evidenced a significant difference for D1 performance between the vehicle-treated and the 0.25-mg/kg groups (17.8 ± 2.5 and 28.7 ± 5.7% respectively; *t* = 3.042; *p* ≤ 0.01). Furthermore, a significant difference for D2 performance was already observed between the vehicle-treated and the 0.25-mg/kg groups (46.3 ± 2.5 and 34.6 ± 6.3% respectively; *t* = 3.284; *p* ≤ 0.01).

3.  Diazepam 0.5 mg/kg. Within-group analyses showed that D1 performance in 0.5 mg/kg treated mice was significantly above chance level (43.8 ± 3.7%; *t* = 5.090; *p* ≤ 0.001) but was at chance for D2 (22.6 ± 3.3%; *t* = 0.719; NS). Bonferroni\'s *t*-test revealed a significant differences between D1 and D2 performance in 0.5 mg/kg treated mice (43.8 ± 3.7 and 22.6 ± 3.3% respectively; *t* = 5.799; *p* ≤ 0.001). In addition, cross-analyses were performed as compared to vehicle-treated group on independent groups of mice. Inter-group comparisons evidenced a significant difference for D1 performance between the vehicle-treated and the 0.5-mg/kg groups (17.8 ± 2.5 and 43.8 ± 3.7% respectively; *t* = 7.286; *p* ≤ 0.001). Furthermore, a significant difference for D2 performance was already observed between the vehicle-treated and the 0.5-mg/kg groups (46.3 ± 2.5 and 22.6 ± 3.3% respectively; *t* = 6.662; *p* ≤ 0.001).

4.  Diazepam 1 mg/kg. The 1-mg/kg treated-mice exhibited significant memory performance for D1 and D2 as compared to chance level (25%; 32.1 ± 1.9%; *t* = 3.576; *p* ≤ 0.01 and 31.7 ± 2.7%; *t* = 2.513; *p* ≤ 0.05 respectively as compared to chance level). Bonferroni\'s *t*-test did not reveal any difference between D1 and D2 (32.1 ± 1.9 and 31.7 ± 2.7% respectively; *t* = 0.103; NS). In addition, inter-group comparisons evidenced a significant difference for D1 performance between the vehicle-treated and the 1-mg/kg groups (17.8 ± 2.5 and 32.1 ± 1.9% respectively; *t* = 3.990; *p* ≤ 0.001). Furthermore, a significant difference for D2 performance was already observed between the vehicle-treated and the 1-mg/kg groups (46.3 ± 2.5 and 31.7 ± 2.7% respectively; *t* = 4.114; *p* ≤ 0.001).

### Elevated plus-maze task

Results are represented in Figure [3](#F3){ref-type="fig"}. Diazepam administration in stressed middle-aged mice induced a significant decrease of entry ratio as compared to placebo (39.9 ± 5.0%) for the dose of 0.5 mg/kg (58.9 ± 2.3%; *p* \< 0.01) and 1.0 mg/kg (54.7 ± 3.1%; *p* \< 0.05). In contrast, diazepam at 0.25 mg/kg did not significantly modified performance as compared to vehicle (46.9 ± 2.3%; NS).

![**Entry ratio in the elevated plus-maze task in vehicle and diazepam (0.25, 0.5, and 1 mg/kg) treated mice**. As can be observed, diazepam at 0.5 and 1.0 mg/kg increased the entry ratio as compared to vehicles, \**p* \< 0.01; \*\**p* \< 0.05. The lower diazepam dose (0.25 mg/kg) induced no significant effect as compared to vehicles.](fnbeh-05-00014-g003){#F3}

Experiment 2: Hippocampal corticosterone levels
-----------------------------------------------

### Basal levels

The basal corticosterone levels in the dialyzate have been analyzed according to the further random attribution of mice to vehicle or diazepam-treated groups.

Basal corticosterone levels in the dialyzate obtained from vehicle-treated mice were 2.71 ± 0.48 nmol/l (*n* = 8), 2.29 ± 0.56 nmol/l (*n* = 8) for 0.25 mg/kg, 1.51 ± 0.49 nmol/l (*n* = 8) for 0.5 mg/kg, 1.77 ± 0.15 nmol/l (*n* = 8) for 1 mg/kg. There were no significant differences in basal extracellular corticosterone levels between: (i) vehicle and 0.25 mg/kg treated mice (*t* = 0.567; NS), (ii) vehicle and 0.5 mg/kg treated mice (*t* = 1.888; NS), (iii) vehicle and 1 mg/kg treated mice (*t* = 1.857; NS).

### Effect of stress

Figure [4](#F4){ref-type="fig"} represents corticosterone levels in the dorsal HPC. Results are expressed in percentage of variation of baseline. Two-way repeated-measures ANOVAs performed on corticosterone kinetic evidenced a significant interaction between Treatments × Time \[*F*~(13,364)~ = 2.801; *p* ≤ 0.001\]. Bonferroni\'s *t*-test did not reveal any difference between the groups (vehicle, 1, 0.5, and 0.25 mg/kg) in the pre-stress period for each factor.

![**Effect of stress on corticosterone concentration into the dorsal HPC**. **(A)** Effect of 0.25 mg/kg diazepam on corticosterone concentration into the dorsal HPC after stress delivery. **(B)** Effect of 0.5 mg/kg diazepam on corticosterone concentration into the dorsal HPC after stress delivery. **(C)** Effect of 1 mg/kg diazepam on corticosterone concentration into the dorsal HPC after stress delivery. Numbers of animals used for each group are mentioned in graphs legends. Dotted lines represent baseline level. Comparisons to vehicle-treated animals: \**p* ≤ 0.05; \*\**p* ≤ 0.01; \*\*\**p* ≤ 0.001.](fnbeh-05-00014-g004){#F4}

1.  Vehicle. As compared to the last pre-stress sample (120.42 ± 25.01%; "time = 0"), stress induced a fast and important increase in corticosterone levels from 15 min after stress (223.77 ± 34.23%; *t* = 4.009; *p* ≤ 0.001) to 120 min (215.27 ± 28.04; *t* = 3.623; *p* ≤ 0.01).

2.  0.25 mg/kg. During the post-stress period, stress induced a fast and rapid increase in corticosterone levels from 15 min after stress (203.36 ± 25.52%; *t* = 3.895; *p* ≤ 0.01) to 105 min (190.56 ± 47.28%; *t* = 3.254; *p* ≤ 0.01) as compared to the last pre-stress sample (113.52 ± 18.10%; "time = 0"). Only the 120 point was no significant (184.03 ± 35.09%; *t* = 1.258; NS) with the last pre-stress sample (113.52 ± 18.10%; "time = 0").

    Furthermore, after the stress delivery, the increase in corticosterone levels observed in 0.25 mg/kg diazepam-treated mice and vehicle-treated mice showed non-significant differences during all the post-stress period (NS in all comparisons).

3.  0.5 mg/kg. As compared to the last pre-stress sample (91.23 ± 14.09%; "time = 0"), stress induced a progressive, and significant increase in corticosterone levels from 15 min after stress (169.89 ± 25.47%; *t* = 3.004; *p* ≤ 0.05) to 75 min (191.21 ± 18.71%; *t* = 3.819; *p* ≤ 0.01). Furthermore, the highest difference was observed 60 min after stress administration (243.51 ± 23.93; *t* = 5.817; *p* ≤ 0.001).

    In addition, a faster increase in corticosterone levels in vehicle-treated mice was observed 15 min after stress delivery as compared 0.5 mg/kg diazepam-treated mice (223.77 ± 34.23 and 169.89 ± 25.47%, respectively; *t* = 2.414; *p* ≤ 0.05) as well as 30 min after stress delivery (238.22 ± 24.60 and 166.62 ± 15.50%, respectively; *t* = 2.295; *p* ≤ 0.05). In contrast, no significant difference was observed between vehicle and 0.5 mg/kg diazepam-treated mice 45, 60, 75, and 90 min after stress delivery (NS in all comparisons). Finally, a faster decrease of corticosterone levels in 0.5 mg/kg diazepam-treated mice was observed as regards to vehicle-treated mice for the 105-min point (172.45 ± 37.95 and 232.86 ± 26.74%, respectively; *t* = 2.690; *p* ≤ 0.05).

4.  --1 mg/kg. As compared to the last pre-stress sample (107.78 ± 8.58%; "time = 0"), the stress-induced rise in corticosterone levels was not observed in 1 mg/kg diazepam-treated mice.

    In consequence, the significant fast and important increase in corticosterone levels in vehicle-treated mice was observed 15 min to the end of the post-stress delay, as compared to 1 mg/kg diazepam-treated mice (223.77 ± 34.23 and 89.63 ± 10.61%, respectively; *t* = 4.575; *p* ≤ 0.001 for 15 post-stress delay; 215.27 ± 28.04 and 104.35 ± 23.27%, respectively; *t* = 3.738; *p* ≤ 0.001 for 120 post-stress delay).

Discussion
==========

The main findings of our study are as follows:

1.  Diazepam significantly decreases anxiety-like reactivity in the elevated plus maze, at the doses of 0.5 and 1.0 mg/kg (but not at the dose of 0.25 mg/kg), as compared to stressed vehicle-injected animals.

2.  Stressed middle-aged mice exhibit a highly significant memory of the second discrimination (D2), while responding at chance (25%) for the first one (D1). Diazepam administration at 0.5 mg/kg totally reverses the memory retrieval pattern in acutely stressed middle-aged animals (D1 \> D2). In contrast, animals receiving the lowest (0.25 mg/kg) and highest (1.0 mg/kg) diazepam doses exhibit similar memory performance for both discriminations even though just above chance level.

3.  Microdialysis experiment shows a significant interaction between diazepam doses and corticosterone concentrations into the HPC. From 0.25 to 0.5 mg/kg, diazepam dose-dependently reduces intra-HPC corticosterone concentrations and in parallel, dose-dependently increased hippocampal memory performance in the CSD task. In contrast, the highest diazepam dose (1.0 mg/kg) induces a reduction in hippocampal corticosterone concentration, which was of greater magnitude as compared to the two other diazepam doses, but however decreased the hippocampal-dependent memory performance (D1) in the CSD task.

Our previous data (Chauveau et al., [@B7], [@B8]; Tronche et al., [@B39],[@B40]) showed that both stress and aging, as well as hippocampal chemical lesions, selectively reduced the retrieval of D1 to chance level (25%) while sparing the retrieval of D2. In the present study, we focused on stressed condition only insofar as stressed middle-aged mice exhibit memory retrieval pattern comparable to non-stressed middle-aged animals, except that stressed subjects exhibit an increase of D2 response of greater magnitude as compared to non-stressed ones. Thus, since our goal was only to determine if diazepam is able to restore a memory retrieval pattern comparable to the level of the one observed in young non-stressed mice (that is to say is able to restore the hippocampal-dependent D1 response), we decided therefore to analyze the effects of diazepam only in the more deleterious condition (middle-aged stressed mice) as compared to non-stress condition.

Our present study confirms the therapeutic anxiolytic action of diazepam. However, in our experimental conditions, this effect is more important for the dose of 0.50 mg/kg (*p* \< 0.01), as compared to 1.0 mg/kg (*p* \< 0.05). Data from the elevated plus-maze test also shows the absence of any sedative effect of diazepam on locomotion for the range of the doses used in our study.

We already showed that the memory retrieval of the first discrimination (D1) but not of the second one (D2) is dependent on the HPC activity, and that both stress and aging affected the memory retrieval of D1 but not of D2 (Celerier et al., [@B5]; Chauveau et al., [@B7], [@B6], [@B8]; Tronche et al., [@B39],[@B40]). Moreover, we also showed previously that in non-stress condition, aging increases HPC corticosterone concentration and abolished the HPC-dependent memory retrieval pattern, as compared to non-stressed young adult mice (Tronche et al., [@B39],[@B40]). Thus, acute stress amplified such endocrinal and cognitive effects of aging, as compared to the non-stress condition.

Our present data evidences a significant memory-enhancing effect of diazepam on HPC-dependent memory performance at the dose of 0.5 mg/kg in stressed middle-aged mice. This finding is at first sight surprising, because of the well-known anterograde and retrograde amnesic properties of BDZ in healthy young adult subjects (for review, Beracochea, [@B2]). However, the memory-enhancing effect observed in the present study as compared to both control animals and chance level for the dose of 0.5 mg/kg may rely on the specificity of the studied population, that is to say stressed middle-aged subjects. The microdialysis experiment shows that diazepam dose-dependently reduces HPC corticosterone concentrations but the memory-enhancing effect is observed only at the 0.5-mg/kg dose. In contrast, whereas the 1.0-mg/kg dose continues to decrease HPC corticosterone concentration, there is a decrease of HPC-dependent memory performance as compared to the 0.5-mg/kg diazepam dose (see Figure [5](#F5){ref-type="fig"}). Thus, the result found with the highest diazepam dose confirms a pejorative effect of diazepam on HPC-dependent memory performance, as compared to the 0.5-mg/kg dose.

![**Synoptic view of the effects of diazepam on both hippocampus corticosterone concentrations (left) and memory performance (D1 test; right)**. Comments are mentioned in the text.](fnbeh-05-00014-g005){#F5}

In addition to the effects of diazepam on hippocampal corticosterone, other actors could also be involved in the dose-dependent effect of BDZ on memory in stress condition, mainly catecholamine, GABA, glutamate, and aspartate. Moreover, changes in GABA/BDZ receptor number and affinity (desensitization) could also be involved.

As shown in Figure [5](#F5){ref-type="fig"}, a key finding is the continuous decrease in HPC corticosterone concentration measured 15 min after stress, as a function of the administered dose of diazepam. From a dynamic point of view (Figure [4](#F4){ref-type="fig"}), the highest diazepam dose totally inhibits the stress-induced HPC corticosterone rise. However, for the 0.50-mg/kg dose, diazepam attenuates the stress-induced corticosterone rise as compared to vehicle-treated animals and accelerates the return to baseline.

From a cognitive point of view, Figure [5](#F5){ref-type="fig"} also shows a bimodal effect of diazepam as a function of the administered dose. Indeed, from 0.0 to 0.5 mg/kg, we observed an inverse relationship between HPC-dependent memory performance and HPC corticosterone concentration. In contrast, from 0.50 to 1.0 mg/kg, the memory performance varies in the same way as the HPC corticosterone level.

The action of diazepam on HPC corticosterone concentrations and memory performance could be explained via the interaction between the GABAergic system and HPC corticosterone as a result of the modulation of HPA axis activity by diazepam.

Indeed, numerous data have clearly demonstrated that HPA axis activity is regulated by non-glucocorticoid inhibitors. There is evidence that HPC-mediated mechanisms of glucocorticoid feedback could involve hypothalamic CRH secretion and GABAergic pathways (Calogero et al., [@B3]; Arvat et al., [@B1]; Cullinan et al., [@B10]). Benzodiazepines (BDZ) activate central GABA receptors, which are importantly distributed in the HPC (Laviv et al., [@B23]; Lehner et al., [@B24]). It has been hypothesized that the effects of GABA/BDZ on HPA activity are mediated by CRH and/or AVP (see Cullinan et al., [@B10]).

The neurotransmitter GABA is a well-known inhibitor of ACTH release (Makara and Stark, [@B27]), probably through a central action on hypothalamic CRH. *In vivo* injection of the GABA-A receptor antagonist bicuculline into the dorsomedial hypothalamus resulted in increased plasma ACTH and corticosterone (Keim and Shekhar, [@B22]). Thus, the HPA axis appears to be under tonic GABA inhibition at the hypothalamic level, mediated through GABA receptors (Häusler et al., [@B17]). Moreover, neuroanatomical and pharmacological studies have established GABA-mediated inhibition of the HPA axis at the level of the PVN (Cullinan et al., [@B10]). Our study is however the first to evidence an *in vivo* direct dynamic interaction between BDZ and corticosterone level in the hippocampus in stress condition.

Glucocorticoids can impair HPC long term potentiation (LTP) *in vitro* (Dubrovsky et al., [@B14]; Pavlides et al., [@B31]) as well as increasing after hyperpolarization mediated by small conductance calcium-activated potassium channels (Joëls and de Kloet, [@B20]) that have been implicated in arousal. Because of the "inverted-U" response to these hormones (Diamond et al., [@B13]), low concentrations maintain, moderate concentrations promote, and high concentrations impair neuronal function. LTP is dependent on adrenal output *in vivo*, and adrenalectomy results in a significant decrease in the extent of LTP (Shors et al., [@B37]). Conversely, stress and excess glucocorticoids impair neuronal function and HPC-dependent memory (reviewed by Sapolsky et al., [@B35]; de Kloet et al., [@B11]; Filipini et al., [@B15]; McEwen and Sapolsky, [@B28]; Lupien and McEwen, [@B25]).

So far, the bimodal modulation of HPC-dependent memory performance according to corticosterone concentrations is in agreement with the study of Diamond et al. ([@B13]), showing that corticosterone exerts a concentration-dependent biphasic influence on the expression of hippocampal plasticity.

Conclusion
==========

Our data evidences a direct interaction between diazepam, HPC corticosterone concentrations, and HPC-dependent memory performance in stressed middle-aged mice. To our knowledge, it is shown here for the first time that diazepam restores memory performance sustained by the hippocampus as previously evidenced (Chauveau et al., [@B8]) so that stressed middle-aged animals receiving the 0.5-mg/kg diazepam dose exhibit a memory pattern similar to the one of young adult non-stressed mice. This effect is related to the level of HPC corticosterone. Overall, our data illustrate how stress and benzodiazepines could modulate cognitive functions depending on hippocampus activity.
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